Regorafenib in metastatic colorectal cancer: Optimal dosing and patient selection recommendations

Axel Grothey

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	514-517
Number of pages	4
Journal	Clinical Advances in Hematology and Oncology
Volume	13
Issue number	8
State	Published - Aug 1 2015

ASJC Scopus subject areas

@article{c0e982d237a54775b5c0067e4adcf708,

title = "Regorafenib in metastatic colorectal cancer: Optimal dosing and patient selection recommendations",

author = "Axel Grothey",

year = "2015",

month = aug,

day = "1",

language = "English (US)",

volume = "13",

pages = "514--517",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "8",

}

TY - JOUR

T1 - Regorafenib in metastatic colorectal cancer

T2 - Optimal dosing and patient selection recommendations

AU - Grothey, Axel

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84939547862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939547862&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 26351814

AN - SCOPUS:84939547862

SN - 1543-0790

VL - 13

SP - 514

EP - 517

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 8

ER -